Dose-dependent systemic human immunodeficiency virus infection of SCID-hu mice after intraperitoneal virus injection. 1995

M Grandadam, and J Y Cesbron, and D Candotti, and D Vinatier, and M Pauchard, and A Capron, and P Debré, and J M Huraux, and B Autran, and H Agut
Laboratoire de Bactériologie-Virologie, CNRS EP57, CERVI, Hôpital Pitié-Salpêtrière, Paris, France.

SCID mice were engrafted with human foetal liver, thymus and lung. Human cells were subsequently detected among peripheral blood leukocytes for 81% of tested animals and in tissue implants for 100% of tested animals. SCID-hu mice received intraperitoneal injections of human immunodeficiency virus type 1 (HIV1) at from 20 up to 20,000 median tissue culture infectious doses (TCID5). HIV1 infection was detected by means of cell culture and polymerase chain reaction both in blood and implants, up to 58 days after infection. The rate of infection was dependent upon the inoculated dose: the frequency of thymus infection ranged from 14% with 20-500 TCID50 up to 100% with 20,000 TCID50. HIV1 infection was detected less frequently in blood leukocytes than in thymus. Thymus virus load ranged from 40 to 50,000 HIV1 provirus copies per million cells and was not correlated with either infectious dose or viraemia. Thymus T-cell depletion was observed mainly in the CD1+4+8+ immature thymocyte compartment. The same rate of SCID-hu mouse infection was obtained using three different primary HIV1 isolates, suggesting that infection was not restricted to a few particular virus strains. The systemic infection of SCID-hu mice following intraperitoneal virus injection mimics some traits of human HIV infection and provides a promising, novel approach for future investigations in this field.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008221 Lymphoid Tissue Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS. Lymphatic Tissue,Lymphatic Tissues,Lymphoid Tissues,Tissue, Lymphatic,Tissue, Lymphoid,Tissues, Lymphatic,Tissues, Lymphoid
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft
D015342 DNA Probes Species- or subspecies-specific DNA (including COMPLEMENTARY DNA; conserved genes, whole chromosomes, or whole genomes) used in hybridization studies in order to identify microorganisms, to measure DNA-DNA homologies, to group subspecies, etc. The DNA probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the DNA probe include the radioisotope labels 32P and 125I and the chemical label biotin. The use of DNA probes provides a specific, sensitive, rapid, and inexpensive replacement for cell culture techniques for diagnosing infections. Chromosomal Probes,DNA Hybridization Probe,DNA Probe,Gene Probes, DNA,Conserved Gene Probes,DNA Hybridization Probes,Whole Chromosomal Probes,Whole Genomic DNA Probes,Chromosomal Probes, Whole,DNA Gene Probes,Gene Probes, Conserved,Hybridization Probe, DNA,Hybridization Probes, DNA,Probe, DNA,Probe, DNA Hybridization,Probes, Chromosomal,Probes, Conserved Gene,Probes, DNA,Probes, DNA Gene,Probes, DNA Hybridization,Probes, Whole Chromosomal

Related Publications

M Grandadam, and J Y Cesbron, and D Candotti, and D Vinatier, and M Pauchard, and A Capron, and P Debré, and J M Huraux, and B Autran, and H Agut
February 1994, The Journal of experimental medicine,
M Grandadam, and J Y Cesbron, and D Candotti, and D Vinatier, and M Pauchard, and A Capron, and P Debré, and J M Huraux, and B Autran, and H Agut
May 1991, Proceedings of the National Academy of Sciences of the United States of America,
M Grandadam, and J Y Cesbron, and D Candotti, and D Vinatier, and M Pauchard, and A Capron, and P Debré, and J M Huraux, and B Autran, and H Agut
February 1991, Science (New York, N.Y.),
M Grandadam, and J Y Cesbron, and D Candotti, and D Vinatier, and M Pauchard, and A Capron, and P Debré, and J M Huraux, and B Autran, and H Agut
March 1991, The Journal of infectious diseases,
M Grandadam, and J Y Cesbron, and D Candotti, and D Vinatier, and M Pauchard, and A Capron, and P Debré, and J M Huraux, and B Autran, and H Agut
October 1995, Journal of medical virology,
M Grandadam, and J Y Cesbron, and D Candotti, and D Vinatier, and M Pauchard, and A Capron, and P Debré, and J M Huraux, and B Autran, and H Agut
December 1999, Journal of virology,
M Grandadam, and J Y Cesbron, and D Candotti, and D Vinatier, and M Pauchard, and A Capron, and P Debré, and J M Huraux, and B Autran, and H Agut
April 2000, Journal of virology,
M Grandadam, and J Y Cesbron, and D Candotti, and D Vinatier, and M Pauchard, and A Capron, and P Debré, and J M Huraux, and B Autran, and H Agut
June 1999, Uirusu,
M Grandadam, and J Y Cesbron, and D Candotti, and D Vinatier, and M Pauchard, and A Capron, and P Debré, and J M Huraux, and B Autran, and H Agut
September 2000, Journal of virology,
M Grandadam, and J Y Cesbron, and D Candotti, and D Vinatier, and M Pauchard, and A Capron, and P Debré, and J M Huraux, and B Autran, and H Agut
March 1996, Journal of virology,
Copied contents to your clipboard!